Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan in HFpEF with secondary pulmonary hypertension
2008-005514-40Phase 2Completed
- Sponsor
- University Teaching Hospital Hall in Tirol
- Start
- Sep 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of bosentan in heart failure with preserved ejection fraction (HFpEF) and pulmonary hypertension due to left heart disease (PH-LHD) (2 arms), sponsored by University Teaching Hospital Hall in Tirol. Started Sep 2008; status: completed.
02
Drugs
bosentan
03
Conditions
heart failure with preserved ejection fraction (HFpEF)pulmonary hypertension due to left heart disease (PH-LHD)
Beyond the preview
Go deeper on 2008-005514-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005514-40.